Dagmara Kuliś

Dagmara Kuliś

Auto-generated profile, based on publicly available information

Dagmara Kuliś

European Organisation for Research and Treatment of Cancer, Brussels, Belgium

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2021 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
CACecilie Delphin Amdal
Cecilie Delphin Amdal
MPMadeline Pe
Madeline Pe
RFRagnhild Sørum Falk
Ragnhild Sørum Falk
CPClaire Piccinin
Claire Piccinin
ABAndrew Bottomley
Andrew Bottomley
KBKristin Bjordal
Kristin Bjordal
Purpose: This systematic review was performed to identify all relevant health-related quality of life (HRQoL) issues associated with COVID-19. Methods: A systematic literature search was undertaken in April 2020. In four teams of three reviewers each, all abstracts were independently reviewed for inclusion by two reviewers. Using a pre-defined checklist of 93 criteria for each publication, data extraction was performed independently by two reviewers and subsequently compared and discussed. If necessary, a third reviewer resolved any discrepancies. The search was updated in February 2021 to retrieve new publications on HRQoL issues including issues related to the long-term consequences of COVID-19. Results: The search in April 2020 identified 3342 potentially relevant publications, and 339 publications were selected for full-text review and data extraction. We identified 75 distinct symptoms and other HRQoL issues categorized into 12 thematic areas; from general symptoms such as fever, myalgia, and fatigue, to neurological and psychological issues. The updated search revealed three extra issues experienced during active disease and long-term problems with fatigue, psychological issues and impaired cognitive function. Conclusion: This first comprehensive systematic review provides a detailed overview of the wide range of HRQoL issues experienced by patients with COVID-19 throughout the course of the disease. It demonstrates the devastating impact of the disease and provides critically important information for clinicians, to enable them to better recognize the disease and to provide knowledge important for treatment and follow-up. The results provided the foundation for the international development of a COVID-19 specific patient-reported HRQoL questionnaire.

1 April 2012 in Expert Review of Pharmacoeconomics & Outcomes Research
Verified
Journal Article
Closed access
MKMichael Koller
Michael Koller
VKValeska Kantzer
Valeska Kantzer
IMIsabelle Mear
Isabelle Mear
KZKatie Zarzar
Katie Zarzar
MMMona Martin
Mona Martin
TTThe Isoqol Tca-Sig
The Isoqol Tca-Sig
Reconciliation refers to the process through which two or more independent forward translations are merged into one single translation. This critical step in the translation process is difficult to formalize. The purpose of this review is to analyze how reconciliation is specified in leading guidelines for the translation of quality-of-life questionnaires and other patient-reported outcome forms with regard to the number and qualifications of individuals involved, the processes followed, as well as the criteria applied. In general, relatively little attention has been paid to characterizing the process in detail. Based on these findings, we specify criteria to be followed.

1 November 2016 in Thyroid®
Verified
Journal Article
Closed access
SSSusanne Singer
Susanne Singer
Olga HussonOlga Husson
Olga Husson
ITIwona Tomaszewska
Iwona Tomaszewska
LLLaura Locati
Laura Locati
NKNAOMI KIYOTA
NAOMI KIYOTA
TFThe Eortc Endocrine Task Force
The Eortc Endocrine Task Force
Background: The objectives of this study were to determine quality of life (QoL) issues that are relevant to thyroid cancer patients cross-culturally, and to identify those with highest relevance to them in addition to the more general issues covered by the core European Organisation for Research and Treatment of Cancer QoL questionnaire (EORTC QLQ-C30). Methods: A systematic literature search provided a list of potentially relevant QoL issues to supplement the core questionnaire EORTC QLQ-C30, which is widely used in research and in care and addresses QoL issues relevant to all groups of cancer patients. A panel of experts revised this list, and thyroid cancer patients rated the issues regarding their relevance for QoL by selecting the 25 issues that they would include in a thyroid cancer–specific QoL module. Results: The literature search and expert discussion provided a list of 71 QoL issues that was rated by thyroid cancer patients (n = 110) from seven countries. All issues were of high priority to at least some of the patients. The most frequently selected issues were sudden attacks of tiredness, exhaustion, quality of sleep, employment, social support, fear of cancer progression, fear of second operation, difficulties swallowing, and globus sensation. Conclusions: Thyroid cancer patients cross-culturally rate fatigue-related issues as highly important for their QoL, calling for increased efforts to find successful treatments for this problem. Vocational rehabilitation is also highly relevant for them and should therefore be an important aim of multidisciplinary care. The third important area of concern is psychological issues, especially fear of progression and of additional treatments.

16 August 2022 in Journal of Clinical Oncology
Verified
Journal Article
Open access
AGAlexandra Gilbert
Alexandra Gilbert
CPClaire Piccinin
Claire Piccinin
GVGalina Velikova
Galina Velikova
MGMogens Groenvold
Mogens Groenvold
DKDagmara Kuliś
Dagmara Kuliś
ABAndrew Bottomley
Andrew Bottomley
PURPOSE: The European Organisation for Research and Treatment of Cancer (EORTC) Item Library is an interactive online platform currently composed of 950 unique items (questions) derived from 67 patient-reported outcome (PRO) questionnaires. PROs complement clinician adverse event (AE) reporting classifications like the Common Terminology Criteria for Adverse Events (CTCAE). This work aims to create a standardized framework using the CTCAE to systematically classify symptomatic AEs from the EORTC Item Library through linking individual items to corresponding AEs. METHODS: The EORTC Item Library items were searched for within the CTCAE (v5.0) and linked to an AE if they were described within the AE's title, description, or grading. Symptoms described in EORTC items but not located in the CTCAE were coded as missing symptoms. Other nonsymptom EORTC items, not described within the CTCAE were assigned a non-CTCAE descriptive classification. Further descriptive codes (eg, multiple issues) were allocated to enable descriptive analysis. Two raters independently coded 26.2% (n = 249) of the items. The remaining 701 items were coded by one rater and verified by the second, followed by discussion with two additional raters to reach consensus. RESULTS: Overall, 625 (65.8%) EORTC items were linked to 208 different AEs. Three hundred sixty-nine items provide information about non-CTCAE cancer–related issues and were categorized into seven descriptive classifications, including body image; emotional impact of a symptom, diagnosis, or treatment; global health and quality of life; and impact on life and daily activities. Inter-rater agreement for independent coding was 79.1%. Bowel urgency and tenesmus were identified as missing symptoms in CTCAEv5.0. CONCLUSION: The EORTC Item Library provides considerable coverage of CTCAE toxicities, along with other complementary issues important to patients with cancer. Using the CTCAE clinical framework to classify symptomatic PRO items may facilitate PRO selection and use in clinical trials and routine care.

9 October 2015 in Cancer
Verified
Journal Article
Closed access
PDF file
MKMichael Koller
Michael Koller
SWSophie Warncke
Sophie Warncke
MHMarianne J. Hjermstad
Marianne J. Hjermstad
JAJuan Arraras
Juan Arraras
CPCecilia Pompili
Cecilia Pompili
OGon behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group and the EORTC Lung Cancer Group
on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group and the EORTC Lung Cancer Group

22 December 2020 in Cancers
Verified
Journal Article
Open access
PDF file
DHDide den Hollander
Dide den Hollander
MFMarco Fiore
Marco Fiore
Javier Martin-BrotoJavier Martin-Broto
Javier Martin-Broto
Bernd KasperBernd Kasper
Bernd Kasper
AHAntonio Casado Herraez
Antonio Casado Herraez
Olga HussonOlga Husson
Olga Husson
Sarcomas comprise 1% of adult tumors and are very heterogeneous. Long-lasting and cumulative treatment side-effects detract from the (progression-free) survival benefit of treatment. Therefore, it is important to assess treatment effectiveness in terms of patient-reported outcomes (PROs), including health-related quality of life (HRQoL) as well. However, questionnaires capturing the unique issues of sarcoma patients are currently lacking. Given the heterogeneity of the disease, the development of such an instrument may be challenging. The study aims to (1) develop an exhaustive list of all HRQoL issues relevant to sarcoma patients and determine content validity; (2) determine a strategy for HRQoL measurement in sarcoma patients. We will conduct an international, multicenter, mixed-methods study (registered at clinicaltrials.gov: NCT04071704) among bone or soft tissue sarcoma patients ≥18 years, using EORTC Quality of Life Group questionnaire development guidelines. First, an exhaustive list of HRQoL issues will be generated, derived from literature and patient (n = 154) and healthcare professional (HCP) interviews (n = 30). Subsequently, another group of sarcoma patients (n = 475) and HCPs (n = 30) will be asked to rate and prioritize the issues. Responses will be analyzed by priority, prevalence and range of responses for each item. The outcome will be a framework for tailored HRQoL measurement in sarcoma patients, taking into account sociodemographic and clinical variables.